The manufacturer of a breast cancer drug which has been deemed "too expensive" to be offered by the NHS has hit back at the decision.
Dr Jayson Dallas, general manager of Roche Products Limited, declared it "an incredible injustice."
Despite Roche offering a significant discount, we are once again disappointed that Nice has not shown any flexibility on access to Kadcyla.
Refusing patients access to this drug is an incredible injustice and tantamount to turning the clock back in cancer research and development. We plan to appeal this decision.
More top news
The mother of a 21-year-old woman who died after taking potentially toxic diet pills has warned others to avoid using the drugs.
It's a case of mistaken identity as the actress is forced to differentiate himself from an Irish activist sharing her name
Jeffrey Okafor is accused of murdering 19-year-old Carl Beatson-Asiedu outside a nightclub in south London in 2009. His trial began today.